Developer docs
API playgroundTry for free, no card

Search company profiles

Mast Group

Full company profile

uuid000mvgp

Namestring
Mast Group
Websiteurl
mast-group.com
Company typeenum
Private
Founded yearint
1959
Descriptiontext

Mast Group is a privately-held medical diagnostics manufacturer and supplier headquartered in Bootle, United Kingdom, founded in 1957. According to its firmographic profile, it manufactures and supplies medical diagnostics products to the pharmaceutical, biotechnology, and healthcare sectors. The company operates a multi-country European footprint, evidenced by dedicated regional websites for the United Kingdom, Germany, and France served from its corporate domain mast-group.com, indicating direct or partnered commercial coverage in those three markets. Specific product lines, technical specifications, certifications, pricing models, customer logos, management team, and financial disclosures are not present in the available source material, so a more granular product or technology description cannot be supported by the data provided.

The company's business model is consistent with a traditional B2B diagnostics supplier: it produces diagnostic products and sells them into pharma, biotech, and healthcare buyers across its three operating geographies. No GTM motion (direct sales versus distribution), pricing model, revenue split by segment, or contract structure is disclosed in the input, so the underlying revenue mechanics cannot be characterised with precision. Headcount is reported in the 101-250 employee band and no parent company, subsidiaries, funding rounds, or M&A activity are recorded in the source, indicating an independent, mature operating entity with no recent capital-markets events captured here.

From an investment-analytics standpoint, the data set is thin. Key fields such as revenue, ownership structure, management team, product catalogue, certifications and compliance, AI capabilities, and recent strategic moves are either unpopulated or explicitly noted as not available. Any investment thesis built on this company would require primary research (management interviews, Companies House filings, distributor references, product catalogues, and quality-system certifications) before claims about moat depth, growth trajectory, or valuation can be made with confidence.

Short descriptiontext

Mast Group is a UK-based, privately-held medical diagnostics manufacturer founded in 1957, supplying diagnostic products to pharmaceutical, biotechnology, and healthcare customers across the United Kingdom, Germany, and France.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBootle, United Kingdom
HQ citystring
Bootle
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
medical diagnostics products, microbiology culture media, in-vitro diagnostics, diagnostic reagents manufacturing, clinical laboratory supplies
Industry3 codes
PRIMARYIMALAIAF
Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes)
SECONDARYIMALAIAD
Medical Device Packaging (Trays, Clamshells, Kits)
SECONDARYHLAMAFAO
Practice Consumables & General Medical Supplies (Needles, Syringes, Gloves, Swabs)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
In-vitro diagnostics manufacturing
No data
Cost components5 values
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mast Group manufactures and supplies medical diagnostics products for the pharmaceutical, biotechnology, and healthcare sectors. The company sells in-vitro diagnostic consumables and related laboratory supplies used by clinical, research, and industrial laboratories. It operates regional commercial sites for the UK, Germany, and France to serve European customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Mast Group is a company with regional operations across the UK, Germany (DE), and France (FR). The homepage indicates regional site selection options but does not provide specific details about individual products, modules, or service offerings based on the limited source content available.

Product and service1 record
1Medical diagnostics products
CategoryIn-vitro diagnostics
Description

Manufactured medical diagnostics products (including diagnostic reagents and consumables) supplied to pharmaceutical, biotechnology, and healthcare laboratories for in-vitro diagnostic and microbiological testing.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized US diagnostics manufacturer focused on molecular and immunoassay reagents and diagnostic kits for infectious disease — closely comparable size and product mix to a diagnostics manufacturer like Mast Group.

TypeBroad incumbent
Description

Provides sample-preparation technologies and molecular diagnostics consumables used by pharma, biotech, and clinical labs — highly comparable in serving diagnostic workflows in healthcare and life sciences.

TypeBroad incumbent
Description

A global leader in in-vitro diagnostics headquartered in France, serving clinical and industrial microbiology, immunoassays, and molecular diagnostics — directly overlapping with Mast Group's medical diagnostics manufacturing focus.

TypeBroad incumbent
Description

US-headquartered life science and clinical diagnostics manufacturer producing quality controls, reagents, and diagnostic instruments — comparable in offering medical diagnostic consumables to pharma, biotech, and healthcare customers.

TypeDirect peer
Description

German mid-market diagnostics manufacturer supplying clinical and food/feed testing reagents — comparable in size, European footprint, and product category to Mast Group.

TypeDirect peer
Description

European in-vitro diagnostics company offering reagents, instruments, and consumables across clinical chemistry, microbiology, and molecular diagnostics — a direct competitor serving similar European hospital and lab customers.

TypeBroad incumbent
Description

Large medical technology company with a significant diagnostics portfolio including immunoassay and clinical chemistry systems and reagents — a broad incumbent in the same European diagnostics market.

TypeBroad incumbent
Description

Operates a substantial diagnostics and microbiology division supplying culture media, identification systems, and consumables — a direct competitor in the IVD and clinical microbiology product space.

9Abbott Diagnostics
TypeBroad incumbent
Description

Global diagnostics division of Abbott producing immunoassays, clinical chemistry, and point-of-care diagnostics — competes broadly with any medical diagnostics manufacturer serving healthcare providers.

TypeBroad incumbent
Description

Diagnostics-focused medical technology company with products in molecular diagnostics, cytology, and infectious disease testing — relevant comparable for diagnostic consumables serving clinical labs and healthcare providers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mast Group

In-vitro diagnostics manufacturingmast-group.com

Mast Group is a UK-based, privately-held medical diagnostics manufacturer founded in 1957, supplying diagnostic products to pharmaceutical, biotechnology, and healthcare customers across the United Kingdom, Germany, and France.

What Mast Group does

Mast Group is a privately-held medical diagnostics manufacturer and supplier headquartered in Bootle, United Kingdom, founded in 1957. According to its firmographic profile, it manufactures and supplies medical diagnostics products to the pharmaceutical, biotechnology, and healthcare sectors. The company operates a multi-country European footprint, evidenced by dedicated regional websites for the United Kingdom, Germany, and France served from its corporate domain mast-group.com, indicating direct or partnered commercial coverage in those three markets. Specific product lines, technical specifications, certifications, pricing models, customer logos, management team, and financial disclosures are not present in the available source material, so a more granular product or technology description cannot be supported by the data provided.

The company's business model is consistent with a traditional B2B diagnostics supplier: it produces diagnostic products and sells them into pharma, biotech, and healthcare buyers across its three operating geographies. No GTM motion (direct sales versus distribution), pricing model, revenue split by segment, or contract structure is disclosed in the input, so the underlying revenue mechanics cannot be characterised with precision. Headcount is reported in the 101-250 employee band and no parent company, subsidiaries, funding rounds, or M&A activity are recorded in the source, indicating an independent, mature operating entity with no recent capital-markets events captured here.

From an investment-analytics standpoint, the data set is thin. Key fields such as revenue, ownership structure, management team, product catalogue, certifications and compliance, AI capabilities, and recent strategic moves are either unpopulated or explicitly noted as not available. Any investment thesis built on this company would require primary research (management interviews, Companies House filings, distributor references, product catalogues, and quality-system certifications) before claims about moat depth, growth trajectory, or valuation can be made with confidence.

Mast Group firmographics

Firmographics
Name
Mast Group
Website
https://mast-group.com
Company type
Private
Founded year
1959
Operating status
Operating
Headcount range
11–50 employees
Short description
Mast Group is a UK-based, privately-held medical diagnostics manufacturer founded in 1957, supplying diagnostic products to pharmaceutical, biotechnology, and healthcare customers across the United Kingdom, Germany, and France.
Ownership category
akta.pro rank

Mast Group industry classification

Industry
Product category
In-vitro diagnostics manufacturing
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYIMALAIAF
Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes)
SECONDARYIMALAIAD
Medical Device Packaging (Trays, Clamshells, Kits)
SECONDARYHLAMAFAO
Practice Consumables & General Medical Supplies (Needles, Syringes, Gloves, Swabs)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies

Keywords

  • Medical diagnostics products
  • Microbiology culture media
  • In-vitro diagnostics
  • Diagnostic reagents manufacturing
  • Clinical laboratory supplies

Where Mast Group is headquartered

Location

Headquarters

HQ city
Bootle
HQ country
United Kingdom
HQ region
Europe

Markets served

Mast Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Mast Group product offering

Product offering

Core offering

Mast Group manufactures and supplies medical diagnostics products for the pharmaceutical, biotechnology, and healthcare sectors. The company sells in-vitro diagnostic consumables and related laboratory supplies used by clinical, research, and industrial laboratories. It operates regional commercial sites for the UK, Germany, and France to serve European customers.

Product overview

Mast Group is a company with regional operations across the UK, Germany (DE), and France (FR). The homepage indicates regional site selection options but does not provide specific details about individual products, modules, or service offerings based on the limited source content available.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical diagnostics products Manufactured medical diagnostics products (including diagnostic reagents and consumables) supplied to pharmaceutical, biotechnology, and healthcare laboratories for in-vitro diagnostic and microbiological testing.

Companies that use Mast Group

Customer profile

Ideal customer profiles1 record

Mast Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mast Group partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights2 records

Mast Group competitors and assessment

Company assessment

Direct peers

  • Meridian Bioscience: Mid-sized US diagnostics manufacturer focused on molecular and immunoassay reagents and diagnostic kits for infectious disease — closely comparable size and product mix to a diagnostics manufacturer like Mast Group.
  • R-Biopharm: German mid-market diagnostics manufacturer supplying clinical and food/feed testing reagents — comparable in size, European footprint, and product category to Mast Group.
  • ELITechGroup: European in-vitro diagnostics company offering reagents, instruments, and consumables across clinical chemistry, microbiology, and molecular diagnostics — a direct competitor serving similar European hospital and lab customers.

Broad incumbents

  • QIAGEN: Provides sample-preparation technologies and molecular diagnostics consumables used by pharma, biotech, and clinical labs — highly comparable in serving diagnostic workflows in healthcare and life sciences.
  • bioMérieux: A global leader in in-vitro diagnostics headquartered in France, serving clinical and industrial microbiology, immunoassays, and molecular diagnostics — directly overlapping with Mast Group's medical diagnostics manufacturing focus.
  • Bio-Rad Laboratories: US-headquartered life science and clinical diagnostics manufacturer producing quality controls, reagents, and diagnostic instruments — comparable in offering medical diagnostic consumables to pharma, biotech, and healthcare customers.
  • Siemens Healthineers: Large medical technology company with a significant diagnostics portfolio including immunoassay and clinical chemistry systems and reagents — a broad incumbent in the same European diagnostics market.
  • Thermo Fisher Scientific (Microbiology & Diagnostics): Operates a substantial diagnostics and microbiology division supplying culture media, identification systems, and consumables — a direct competitor in the IVD and clinical microbiology product space.
  • Abbott Diagnostics: Global diagnostics division of Abbott producing immunoassays, clinical chemistry, and point-of-care diagnostics — competes broadly with any medical diagnostics manufacturer serving healthcare providers.
  • Hologic: Diagnostics-focused medical technology company with products in molecular diagnostics, cytology, and infectious disease testing — relevant comparable for diagnostic consumables serving clinical labs and healthcare providers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Mast Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mast Group leadership team

Management profile

Number of profiles

Mast Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mast Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mast Group

What does Mast Group do?

Mast Group manufactures and supplies medical diagnostics products for the pharmaceutical, biotechnology, and healthcare sectors. The company sells in-vitro diagnostic consumables and related laboratory supplies used by clinical, research, and industrial laboratories. It operates regional commercial sites for the UK, Germany, and France to serve European customers.

When was Mast Group founded?

Mast Group was founded in 1959. It employs 11 to 50 people.

Where is Mast Group based?

Mast Group is headquartered in Bootle, United Kingdom, in the Europe region.

Who are Mast Group's main competitors?

Direct peers on record are Meridian Bioscience, R-Biopharm and ELITechGroup. Broad incumbents are QIAGEN, bioMérieux, Bio-Rad Laboratories, Siemens Healthineers, Thermo Fisher Scientific (Microbiology & Diagnostics), Abbott Diagnostics and Hologic.

Does Mast Group have an API?

No public API is recorded for Mast Group.

What industry is Mast Group in?

Mast Group's product category is In-vitro diagnostics manufacturing. Its primary akta.pro industry code is IMALAIAF, Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes), with a secondary code of IMALAIAD, Medical Device Packaging (Trays, Clamshells, Kits). Its NAICS code is 325413 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Med-Tech InsightsWinners announced at Medilink Healthcare Business AwardsMedilink North of England Healthcare Business Awards 2026 were held in Sheffield on 30 April, marking 30 years of the association. Winners included Mitotype Precision Labs, JRI Orthopaedics, and others across categories. The event was supported by Equans Sci-Tech and featured a keynote by Professor Shafi Ahmed.GlobeNewswireNanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group LimitedNanomix entered a multi-region distribution agreement with Mast Group to market and distribute its eLab system in the UK, Germany, France, Ireland, and South Africa. The system provides rapid point-of-care diagnostics for sepsis and pneumonia, with results in about 12 minutes. Mast will support assay expansions to complement its growth areas.PR NewswireSeegene va fournir des tests de diagnostic COVID-19 d'une valeur de 16 millions de livres sterling à l'Écosse, soit le triple du volume des ventes de l'année dernièreSeegene Inc., a South Korean biotechnology company, has begun supplying COVID-19 diagnostic tests worth £16,209,150 to Scotland via a public procurement agreement with National Health Care Scotland NSS, with distribution handled by Scottish dealer Mast Group to nine hospitals including the Royal Infirmary Edinburgh and Ninewell from April 2021. The contract represents three times Seegene's annual Scottish sales volume in 2020 (£5.4 million), marking the highest diagnostic volume in the region since the pandemic. Seegene, which recently obtained CE-IVD marking for its variant detection tests in March, indicated readiness to supply those tests to Scotland upon government request and sees the deal as a pathway to selling additional diagnostic products such as STI and HPV tests in the region.PR NewswireSeegene liefert COVID-19-Diagnosetests im Wert von 16 mil. GBP nach Schottland, das Dreifache des Umsatzvolumens des letzten JahresSeegene Inc. has begun delivering COVID-19 diagnostic tests worth 16.2 million GBP to Scotland, marking a threefold increase over its previous annual sales volume in the region. The contracts involve supplying Allplex™ SARS CoV-2 PCR Kits to nine hospitals via distributor Mast Group, utilizing Seegene's multiplex real-time PCR technology. This agreement follows a significant recent contract win in Italy valued at 89.3 million euros, highlighting the company's expanding market presence.PR NewswireSeegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last yearSeegene Inc. has begun supplying COVID-19 diagnostic tests valued at approximately 16.2 million GBP to Scotland under a public procurement agreement, representing triple the sales volume recorded in 2020. The Allplex™ SARS CoV-2 assays will be distributed via dealership Mast Group to nine hospitals across the region, with Seegene indicating readiness to supply variant-specific tests if demanded by the Scottish government.